These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38229490)

  • 1. The relative isoform expression levels of isocitrate dehydrogenase in breast cancer: IDH2 is a potential target in MDA-MB-231 cells.
    Piao S; Kim S; Seo Y; Lee J; Jeon S; Vu GH; Yeo MK; Kim CS
    Korean J Clin Oncol; 2023 Dec; 19(2):60-68. PubMed ID: 38229490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases.
    Minemura H; Takagi K; Sato A; Yamaguchi M; Hayashi C; Miki Y; Harada-Shoji N; Miyashita M; Sasano H; Suzuki T
    Breast Cancer; 2021 Jul; 28(4):915-926. PubMed ID: 33713004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of both mitochondrial isocitrate dehydrogenase enzymes in pancreatic beta cells inhibits insulin secretion.
    MacDonald MJ; Brown LJ; Longacre MJ; Stoker SW; Kendrick MA; Hasan NM
    Biochim Biophys Acta; 2013 Nov; 1830(11):5104-11. PubMed ID: 23876293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
    Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU
    J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
    Krell D; Assoku M; Galloway M; Mulholland P; Tomlinson I; Bardella C
    PLoS One; 2011; 6(5):e19868. PubMed ID: 21625441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells.
    Smolková K; Dvořák A; Zelenka J; Vítek L; Ježek P
    Int J Biochem Cell Biol; 2015 Aug; 65():125-33. PubMed ID: 26007236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of members of the isocitrate dehydrogenase gene family in murine inner ear.
    Kim YR; Kim KH; Lee S; Oh SK; Park JW; Lee KY; Baek JI; Kim UK
    Biotech Histochem; 2017; 92(7):536-544. PubMed ID: 28925723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma.
    Miyake K; Baba Y; Ishimoto T; Hiyoshi Y; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Ogata Y; Nagayama M; Silsirivanit A; Kobayashi D; Araki N; Baba H
    Med Oncol; 2018 Nov; 36(1):11. PubMed ID: 30506321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isocitrate Dehydrogenase
    Murugan AK; Alzahrani AS
    Br J Biomed Sci; 2022; 79():10208. PubMed ID: 35996504
    [No Abstract]   [Full Text] [Related]  

  • 10. 2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.
    Jin G; Reitman ZJ; Spasojevic I; Batinic-Haberle I; Yang J; Schmidt-Kittler O; Bigner DD; Yan H
    PLoS One; 2011 Feb; 6(2):e16812. PubMed ID: 21326614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancers.
    Raynaud S; Carbuccia N; Colin C; Adélaïde J; Mozziconacci MJ; Metellus P; Chinot O; Birnbaum D; Chaffanet M; Figarella-Branger D
    Oncol Lett; 2010 Sep; 1(5):883-884. PubMed ID: 22966399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer.
    Liu Y; Xu W; Li M; Yang Y; Sun D; Chen L; Li H; Chen L
    Acta Pharm Sin B; 2023 Apr; 13(4):1438-1466. PubMed ID: 37139412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.
    Ward PS; Lu C; Cross JR; Abdel-Wahab O; Levine RL; Schwartz GK; Thompson CB
    J Biol Chem; 2013 Feb; 288(6):3804-15. PubMed ID: 23264629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer.
    Sharma H
    Curr Top Med Chem; 2018; 18(6):505-524. PubMed ID: 29773061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells.
    Zhang Y; Lv W; Li Q; Wang Q; Ru Y; Xiong X; Yan F; Pan T; Lin W; Li X
    Mol Med Rep; 2019 Aug; 20(2):1893-1900. PubMed ID: 31257503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d-2-hydroxyglutarate oncometabolite level in dedifferentiated chondrosarcoma.
    Mohammad N; Wong D; Lum A; Lin J; Ho J; Lee CH; Yip S
    Histopathology; 2020 Apr; 76(5):722-730. PubMed ID: 31609487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis.
    Yoshimi N; Futamura T; Bergen SE; Iwayama Y; Ishima T; Sellgren C; Ekman CJ; Jakobsson J; Pålsson E; Kakumoto K; Ohgi Y; Yoshikawa T; Landén M; Hashimoto K
    Mol Psychiatry; 2016 Nov; 21(11):1504-1510. PubMed ID: 26782057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.
    Li JJ; Yu T; Zeng P; Tian J; Liu P; Qiao S; Wen S; Hu Y; Liu Q; Lu W; Zhang H; Huang P
    Nat Commun; 2024 Apr; 15(1):3445. PubMed ID: 38658533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocitrate dehydrogenase 1-snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability.
    Liu WS; Chan SH; Chang HT; Li GC; Tu YT; Tseng HH; Fu TY; Chang HY; Liou HH; Ger LP; Tsai KW
    Breast Cancer Res; 2018 Apr; 20(1):25. PubMed ID: 29661250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting isocitrate dehydrogenase (IDH) in cancer.
    Fujii T; Khawaja MR; DiNardo CD; Atkins JT; Janku F
    Discov Med; 2016 May; 21(117):373-80. PubMed ID: 27355333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.